In Conversation with Andrew Baum: Exploring Pfizer’s Long-Term Vision

August 26, 2025

As Pfizer’s Chief Strategy and Innovation Officer, Andrew Baum, MD, BM ChB, is responsible for advancing the company’s long-term corporate strategic plan to maximize value for patients and shareholders. He also plays a vital role in overseeing business development activities, strengthening partnerships within the biotech ecosystem, and leading the commercial evaluation of our research pipeline.

Dr. Baum recently sat down with Francesca DeMartino, our Chief Investor Relations Officer, to discuss Pfizer’s approach to harnessing innovation, both within our pipeline and through strategic business development. He sees strong potential for growth and innovation across Pfizer’s four key therapeutic areas – Oncology, Vaccines, Internal Medicine, and Inflammation & Immunology.

“There's more to come [in terms of business development], and investors should expect that we're going to be very active, taking the brightest prospects and investing in it – and bringing Pfizer's expertise to maximize the value of those assets going forward.”

Watch this video with Dr. Baum to hear more about the perspective he brings to Pfizer and his vision for the company’s strategic direction.

Forward-looking statements included herein, including those related to our anticipated operating and financial performance, including our financial guidance, our product and pipeline advancements, our strategic priorities, our cost realignment program and our efforts to return value to shareholders, are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.

Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.